Term Description

This belongs to the set of Collaborative Staging (CS) data items effective with 2004 diagnosis. The "CS Site-Specific Factor" items (1-6) are used to code additional site-specific information needed to derive TNM or AJCC stage, or to code prognostic factors that have an effect on stage or survival. Some site-specific information that was formerly recorded in "EOD--Tumor Size" [780] (Breslow's Thickness for melanoma; HIV/AIDS status for lymphoma) is now also in "CS Site-Specific Factor" items. Many site-specific schemas do not use any of the Site-Specific Factors; other schemas use from 1 to all 6 of the factors... NAACCR Data Standards and Data Dictionary Version 11

LOINC Names Get Info

Fully-Specified Name
Collaborative staging site-specific factor 4:Prid:Pt:Cancer.XXX:Nom:
Long Common Name
Collaborative staging site-Specific factor 4 Cancer
Short Name
CS site-Specific factor 4 Cancer

Part Model Get Info

  • Component
    Collaborative staging site-Specific factor 4
    LP72287-3
    • Analyte
      Collaborative staging site-Specific factor 4
      LP72287-3
      • Component Numerator
        Collaborative staging site-Specific factor 4
        LP72287-3
        • Component Numerator Core
          Collaborative staging site-Specific factor 4
          LP72287-3
        • Component Numerator Core Suffix
          NULL
           
      • Component Denominator
        NULL
         
        • Component Denominator Core
          NULL
           
        • Component Denominator Core Suffix
          NULL
           
    • Challenge
      NULL
       
    • Adjustment
      NULL
       
    • Count
      NULL
       
  • Property
    Prid
    LP6850-4
  • Time
    Pt
    LP6960-1
  • System
    Cancer.XXX
    LP7102-9
    • System Core
      Cancer.XXX
      LP7102-9
    • Super System
      NULL
       
  • Scale
    Nom
    LP7750-5
  • Method
    NULL
     

Basic Attributes

Class
TUMRRGT
Type
Clinical
First Released
Version 2.16
Last Updated
Version 2.27 (MIN)

Member of these Panels

LOINCLong Common Name
49083-9North American Association of Central Cancer Registries, Inc (NAACCR, Inc) version 11 panel
59852-4North American Association of Central Cancer Registries, Inc (NAACCR, Inc) version 12 panel

Language Variants Get Info

TagLanguageTranslation
el-GRGreek (Greece)Συνεργατική σταδιοποίηση-Τοποειδικός παράγοντας 4:Prid:Pt:Καρκίνος.XXX:Nom:
Synonyms: Nom Prid Pt TUMRRGT XXX Καρκίνος Καρκίνος.XXX Σταδιοποίηση Συνεργατική σταδιοποίηση-Τοποειδικός παράγοντας 4
es-MXSpanish (Mexico)Factor 4 específico del sitio de estadificación colaborativa:Tipo:Punto temporal:Cancer.XXX:Nominal:
it-ITItalian (Italy)Collaborative staging, fattore 4 sito-specifico:Prid:Pt:Cancro.XXX:Nom:
Synonyms: Cancro XXX Neoplasia maligna Presenza o Identità Punto nel tempo (episodio) Registro tumori
ru-RURussian (Russian Federation)Объединенное определение стадии место-специфический фактор 4:ПрИд:ТчкВрм:Рак.XXX:Ном:
Synonyms: Номинальный;Именной Присутствие или Идентификация Точка во времени;Момент
zh-CNChinese (China)协作分期 部位特异性因素 4:存在与否或特征标识:时间点:癌.XXX:名义型:
Synonyms: Collaborative Staging;CS;协作分期 NAACCR 肿瘤登记;癌症登记中心北美协会肿瘤登记;肿瘤注册;肿瘤登记(NAACCR);肿瘤登记(癌症登记中心北美协会);癌症登记中心北美协会;North American Association of Central Cancer Registries;NAACCR 不明癌;不明癌症;未作说明的癌;未作说明的癌症;癌.不明;癌.未作说明的;癌症.XXX;癌症.不明;癌症.未作说明的;此处未作说明的癌 不明的;其他;将在相应消息内其他部分之中加以详细说明;未作详细说明的;未作说明的;未做说明的标本;未加规定的;未加说明的标本;杂项 位点;位置 分类型应答;分类型结果;名义性;名称型;名词型;名词性;标称性;没有自然次序的名义型或分类型应答 分级;阶段划分;等级划分 因素 存在;存在与否;特征标识;身份;身份标识 时刻;随机;随意;瞬间 特异 特异性的 特异的 癌 系数

LOINC Terminology Service (API) using HL7® FHIR® Get Info

CodeSystem lookup
https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=42089-3